Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats

Psychopharmacology

Volumn 179, Issue 1, 2005, Pages 128-135

  Zakharova, E S ^a   Danysz, W ^b   Bespalov, A Y ^a,c  

^a PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

^c ABBOTT GMBH AND CO KG   (Germany)

Author keywords

Dopamine receptor antagonist; Drug discrimination; Metabotropic glutamate receptor antagonist; Nicotine; Nicotinic receptor antagonist; NMDA receptor antagonist; Rat

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; DEXTROMETHORPHAN; DIZOCILPINE; MECAMYLAMINE; MEMANTINE; MRZ 2 261; MRZ 2 621; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINE TARTRATE; NICOTINIC RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG STRUCTURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; REINFORCEMENT; STRUCTURE ANALYSIS; TASK PERFORMANCE;

ANIMALS; DISCRIMINATION LEARNING; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MECAMYLAMINE; MEMANTINE; NICOTINE; NICOTINIC ANTAGONISTS; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 17744396099     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2067-4     Document Type: Article

References (33)

1. Bespalov AY, Beardsley PM, Balster RL (1998) Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats. Pharmacol Biochem Behav 60:507-517
2. Briggs CA, McKenna DG (1996) Effect of MK-801 at the human alpha 7 nicotinic acetylcholine receptor. Neuropharmacology 35:407-414
3. Brioni JD, Kim DJ, O'Neill AB (1996) Nicotine cue: lack of effect of the alpha 7 nicotinic receptor antagonist methyllycaconitine. Eur J Pharmacol 301:1-5
4. Buisson B, Bertrand D (1998) Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 53:555-563
5. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346-356
6. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G (1997) Aminoadamantanes as NMDA receptor antagonists and anti-parkinsonian agents - preclinical studies. Neurosci Biobehav Rev 21:455-468
7. Fu Y, Matta SG, Gao W, Brower VG, Sharp BM (2000) Systemic nicotine stimulates dopamine release in nucleus accumbens: reevaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area. J Pharmacol Exp Ther 294:458-465
8. Gasparini F, Lingenhohl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I, Biollaz M, Allgeier H, Heckendorn R, Urwyler S, Varney MA, Johnson EC, Hess SD, Rao SP, Sacaan AI, Santori EM, Velicelebi G, Kuhn R (1999) 2-Methyl-6- (phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38:1493-1503
9. Gilling KE, Weston A, Jatzke C, Parsons CG, Danysz W (2002) Are the beneficial therapeutic effects of neuronal nicotinic receptor agonists due to activation or inactivation/desensitization of alpha7 and alpha4beta2 receptors. Abstr Soc Neurosci 28, 432.17
10. Glick SD, Maisonneuve IM, Dickinson HA, Kitchen BA (2001) Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats. Eur J Pharmacol 422:87-90
11. Glick SD, Maisonneuve IM, Kitchen BA (2002) Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors. Eur J Pharmacol 448:185-191
12. Gommans J, Stolerman IP, Shoaib M (2000) Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice. Neuropharmacology 39:2840-2847
13. Hernandez SC, Bertolino M, Xiao Y, Pringle KE, Caruso FS, Kellar KJ (2000) Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors. J Pharmacol Exp Ther 293:962-967
14. Homayoun H, Stefani MR, Adams BW, Tamagan GD, Moghaddam B (2004) Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release. Neuropsychopharmacology 29:1259-1269
15. Hundt W, Danysz W, Holter SM, Spanagel R (1998) Ethanol and N-melhyl-D-asparlale receptor complex interactions: a detailed drug discrimination study in the rat. Psychopharmacology (Berl) 135:44-51
16. Kantak KM, Edwards MA, O'Connor TP (1998) Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists. Pharmacol Biochem Behav 59:159-169
17. Koek W, Colpaert FC, Vignon J (1993) Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection. J Pharmacol Exp Ther 264:746-756
18. Koek W, Kleven MS, Colpaert FC (1995) Effects of the NMDA antagonist, dizocilpine, in various drug discriminations: characterization of intermediate levels of drug lever selection. Behav Pharmacol 6:590-600
19. Löscher W, Potschka H, Wlaz P, Danysz W, Parsons CG (2003) Are neuronal nicotinic receptors a target for antiepileptic drug development? Studies in different seizure models in mice and rats. Eur J Pharmacol 466:99-111
20. Mansbach RS, Chambers LK, Rovetti CC (2000) Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine. Psychopharmacology (Berl) 148:234-242
21. Mansvelder HD, McGehee DS (2000) Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27:349-357
22. Mansvelder HD, Keath JR, McGehee DS (2002) Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33:905-919
23. Papke RL, Sanberg PR, Shytle RD (2001) Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J Pharmacol Exp Ther 297:646-656
24. Paterson NE, Semenova S, Gasparini F, Markou A (2003) The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl) 167:257-264
25. Pulvirenti L, Balducci C, Koob GF (1997) Dextromethorphan reduces intravenous cocaine self-administration in the rat. Eur J Pharmacol 321:279-283
26. Schilstrom B, Fagerquist MV, Zhang X, Hertel P, Panagis G, Nomikos GG, Svensson TH (2000) Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse 38:375-383
27. Shoaib M, Benwell ME, Akbar MT, Stolerman IP, Balfour DJ (1994) Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists. Br J Pharmacol 111:1073-1080
28. Stolerman IP, Pratt JA, Garcha HS, Giardini V, Kumar R (1983) Nicotine cue in rats analysed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms. Neuropharmacology 22:1029-1037
29. Stolerman IP, Chamberlain S, Bizarro L, Fernandes C, Schalkwyk L (2004) The role of nicotinic receptor alpha 7 subunits in nicotine discrimination. Neuropharmacology 46:363-371
30. Takayama H, Majewska MD, London ED (1989) Interactions of noncompetitive inhibitors with nicotinic receptors in the rat brain. J Pharmacol Exp Ther 251:1083-1089
31. Willetts J, Balster RL (1989) Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists. J Pharmacol Exp Ther 249:438-443
32. Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA (2003) Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci 23:3176-3185
33. Young R, Glennon RA (2002) Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol 443:113-118